Neuralgia
📧 Sign up to get email alerts when something new happens for Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-01-22Clinical Trial Update: Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study [Phase 4]
Phase 4 study on identifying patients with chronic neuropathic low back pain was withdrawn.
-
EMA withdrawal · 2015-04-24EMA Application withdrawn: Duloxetine Sandoz (duloxetine) — Sandoz GmbH
EMA withdrawn application for Duloxetine Sandoz (duloxetine) by Sandoz GmbH.